Tuesday, June 16, 2020

Cardiff Oncology Raises $13.5M

San Diego-based Cardiff Oncology said this morning that it has raised $13.5M in an equity funding round. The company, which is working on drugs to treat cancer, said the funding was led by Acorn Bioventures and CAM Capital. The company said the funding will go to accelerate the development of its lead compound, onvansertib, and also for associate

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.